Your browser doesn't support javascript.
loading
Radical surgical resection with molecular margins is associated with improved survival in IDH wildtype GBM.
Massaad, Elie; Smith, William J; Bradley, Joseph; Esposito, Eric; Gupta, Mihir; Burns, Evan; Burns, Ryan; Velarde, José K; Berglar, Inka K; Gupta, Rajiv; Martinez-Lage, Maria; Dietrich, Jorg; Lennerz, Jochen K; Dunn, Gavin P; Jones, Pamela S; Choi, Bryan D; Kim, Albert E; Frosch, Matthew; Barker, Fred G; Curry, William T; Carter, Bob S; Nahed, Brian V; Cahill, Daniel P; Shankar, Ganesh M.
Afiliación
  • Massaad E; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Smith WJ; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Bradley J; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Esposito E; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Gupta M; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Burns E; Dept of Neurosurgery, Yale New Heaven Health, New Haven, CT.
  • Burns R; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Velarde JK; Jacobs School of Medicine, University of Buffalo, Buffalo, NY.
  • Berglar IK; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Gupta R; Boston College, Newton, MA.
  • Martinez-Lage M; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Dietrich J; Dept of Radiology, Massachusetts General Hospital, Boston, MA.
  • Lennerz JK; Dept of Radiology, Massachusetts General Hospital, Boston, MA.
  • Dunn GP; Dept of Pathology, Massachusetts General Hospital, Boston, MA.
  • Jones PS; Dept of Neurology, Massachusetts General Hospital, Boston, MA.
  • Choi BD; Dept of Pathology, Massachusetts General Hospital, Boston, MA.
  • Kim AE; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Frosch M; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Barker FG; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Curry WT; Dept of Neurology, Massachusetts General Hospital, Boston, MA.
  • Carter BS; Dept of Pathology, Massachusetts General Hospital, Boston, MA.
  • Nahed BV; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Cahill DP; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
  • Shankar GM; Dept of Neurosurgery, Massachusetts General Hospital, Boston, MA.
Neuro Oncol ; 2024 Apr 06.
Article en En | MEDLINE | ID: mdl-38581292
ABSTRACT

BACKGROUND:

Survival is variable in patients with glioblastoma IDH wild-type (GBM), even after comparable surgical resection of radiographically-detectable disease, highlighting the limitations of radiographic assessment of infiltrative tumor anatomy. The majority of post-surgical progressive events are failures within 2cm of the resection margin, motivating supramaximal resection strategies to improve local control. However, which patients benefit from such radical resections remains unknown.

METHODS:

We developed a predictive model to identify which IDH wild-type GBM are amenable to radiographic gross total resection (GTR). We then investigated whether GBM survival heterogeneity following GTR is correlated with microscopic tumor burden a by analyzing tumor cell content at the surgical margin with a rapid qPCR-based method for detection of TERT promoter mutation.

RESULTS:

Our predictive model for achievable GTR, developed on retrospective radiographic and molecular data of GBM patients undergoing resection, had an AUC of 0.83, sensitivity of 62%, and specificity of 90%. Prospective analysis of this model in 44 patients found 89% of patients were correctly predicted to achieve a RV<4.9cc. Of the 44 prospective patients undergoing rapid qPCR TERT promoter mutation analysis at the surgical margin, 7 had undetectable TERT mutation, of which 5 also had a gross total resection (RV<1cc). In these 5 patients at 30 months follow up, 75% showed no progression, compared to 0% in the group with TERT mutations detected at the surgical margin (p=0.02).

CONCLUSIONS:

These findings identify a subset of patients with GBM that may derive local control benefit from radical resection to undetectable molecular margins.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Marruecos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Idioma: En Revista: Neuro Oncol Asunto de la revista: NEOPLASIAS / NEUROLOGIA Año: 2024 Tipo del documento: Article País de afiliación: Marruecos
...